Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions.

Literature DB >> 27486200

Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions.

Maximilian Boesch^1,2, Sieghart Sopper^2,3, Dominik Wolf⁴.

Abstract

Year: 2016 PMID： 27486200 PMCID： PMC5189623 DOI： 10.1634/theoncologist.2016-0159

Source DB: PubMed Journal: Oncologist ISSN： 1083-7159

× No keyword cloud information.

31 in total

1. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein.

Authors: Ju-Hwa Kim; Minji Chae; Won Ki Kim; You-Jin Kim; Han Sung Kang; Hyung Sik Kim; Sungpil Yoon
Journal: Br J Pharmacol Date: 2011-02 Impact factor: 8.739

Review 2. Tumour stem cells and drug resistance.

Authors: Michael Dean; Tito Fojo; Susan Bates
Journal: Nat Rev Cancer Date: 2005-04 Impact factor: 60.716

3. Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice.

Authors: Wolfgang Boehmerle; Hanna Muenzfeld; Andreas Springer; Petra Huehnchen; Matthias Endres
Journal: J Mol Med (Berl) Date: 2014-04-27 Impact factor: 4.599

4. Geno- and cytotoxicity of salinomycin in human nasal mucosa and peripheral blood lymphocytes.

Authors: Agmal Scherzad; Stephan Hackenberg; Carolin Schramm; Katrin Froelich; Christian Ginzkey; Rudolf Hagen; Norbert Kleinsasser
Journal: Toxicol In Vitro Date: 2015-03-10 Impact factor: 3.500

5. Identification of cells initiating human melanomas.

Authors: Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal: Nature Date: 2008-01-17 Impact factor: 49.962

Ionophore Antibiotics as Cancer Stem Cell-Selective Drugs: Open Questions.

1. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein.

Review 2. Tumour stem cells and drug resistance.

3. Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice.

4. Geno- and cytotoxicity of salinomycin in human nasal mucosa and peripheral blood lymphocytes.

5. Identification of cells initiating human melanomas.

6. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.

7. Salinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells.

Review 8. Salinomycin as a drug for targeting human cancer stem cells.

9. The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics.

10. High prevalence of side population in human cancer cell lines.

1. Interaction of crown ethers with the ABCG2 transporter and their implication for multidrug resistance reversal.

Review 2. Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche.

3. Crown ethers reverse P-glycoprotein-mediated multidrug resistance in cancer cells.

4. Evaluation of Vav3.1 as prognostic marker in endometrial cancer.